What is Morgan Stanley's price target for PFE?

Morgan Stanley's latest stated price target for Pfizer Inc. (PFE) is $55, from its action on Apr 6, 2022.

What is Morgan Stanley's rating on PFE?

Morgan Stanley rates PFE Equal-Weight, a neutral rating, as of Apr 6, 2022.

When did Morgan Stanley last change its view on PFE?

On Apr 6, 2022, Morgan Stanley resumes coverage at Equal-Weight, price target $55.

Morgan Stanley PFE price target and rating history

Morgan Stanley rates Pfizer Inc. (PFE) Equal-Weight with a $55 price target, as of its latest action on Apr 6, 2022. It has published 5 rating actions on PFE since July 2021, including 0 upgrades and 0 downgrades. Across 7 firms with a PFE price target in the last 12 months, the median target is $26.

Current rating: Equal-Weight
Price target: $55
Median target, all firms: $26
Actions on PFE: 5

Morgan Stanley price target on PFE

Morgan Stanley price target on PFE, each point a stated target, July 2021 to April 2022.

Every Morgan Stanley rating on PFE

Apr 6, 2022
ResumeMorgan Stanley resumes coverage at Equal-Weight, price target $55
Feb 10, 2022
ReiterateMorgan Stanley cuts its price target to $55 from $60, keeps Equal-Weight
Nov 29, 2021
ReiterateMorgan Stanley raises its price target to $60 from $50, keeps Equal-Weight
Oct 12, 2021
ReiterateMorgan Stanley raises its price target to $48 from $45, keeps Equal-Weight
Jul 29, 2021
ReiterateMorgan Stanley raises its price target to $45 from $42, keeps Equal-Weight

How other firms rate PFE

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
DZ Bank	Hold		Nov 6, 2026
HSBC	Hold	$28	Jul 6, 2026
RBC Capital Markets	Sector Perform	$25	Jun 10, 2026
Argus Research	Buy	$35	Mar 2, 2026
Barclays	Underweight	$25	Feb 20, 2026
Daiwa	Neutral	$27	Feb 12, 2026
UBS	Neutral	$25	Jan 7, 2026
Citigroup	Neutral	$26	Dec 2, 2025

Questions about Morgan Stanley and PFE

What is Morgan Stanley's price target for PFE?: Morgan Stanley's latest stated price target for Pfizer Inc. (PFE) is $55, from its action on Apr 6, 2022.
What is Morgan Stanley's rating on PFE?: Morgan Stanley rates PFE Equal-Weight, a neutral rating, as of Apr 6, 2022.
When did Morgan Stanley last change its view on PFE?: On Apr 6, 2022, Morgan Stanley resumes coverage at Equal-Weight, price target $55.
How does Morgan Stanley's PFE target compare with other analysts?: Across 7 firms with a PFE price target in the last 12 months, the median target is $26.

More PFE rating histories

All Morgan Stanley ratings PFE news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.